News & Analysis on Clinical Trial Services & Contract Research And Development
A new therapy for Parkinson's disease involving brain implants has been developed by US scientists, who believe this new treatment is a viable alternative to drugs currently used to treat this chronic irreversible brain condition.
US drug company, Eli Lilly, offered a more encouraging outlook than was expected forecasting an earnings growth of up to 12 per cent, a stark contrast to its struggling competitors, who also face generic competition, drug safety and regulation.
Solexa has announced the introduction of its DNA sequencing, expression profiling and micro-RNA analysis platform designed to generate over a billion bases of sequence per run, making it ideal for plans to sequence the entire human genome in 2006.
Thermo Electron Corporation, have added to its crystallisation range with the new compact, entry-level, TableStore, which enhances protein structure and drug discovery investigations by offering optical clarity and automated storage capabilities...
Shanghai-based biotech company WuXi PharmaTech has grown more than 100 times in the last 5 years after operating successfully in China's infant biotech industry by providing variety of outsourcing services in drug R&D.
Ventiv health reported a strong performance across all its business units in the third quarter, with total revenues increasing by 44 per cent to $128.4 million (€107.6 million) compared to the third quarter of 2004.
CuraGen and TopoTarget have announced preliminary data suggesting its small molecule candidate may have potential anti-tumour activity against haematologic cancer.